Submission Details

Molecule(s):
CN(C)c1ccc(N(Cc2ccsc2)C(=O)Cc2cncc3ccccc23)cc1

PET-UNK-1901c25b-1

CN(C)c1ccc(N(Cc2ccsc2)C(=O)Cc2cncc3ccccc23)cc1

3-aminopyridine-like Assayed Check Availability on Manifold View
CS(=O)(=O)c1ccc(N(Cc2ccsc2)C(=O)Cn2nnc3ccccc32)cc1

PET-UNK-1901c25b-2

CS(=O)(=O)c1ccc(N(Cc2ccsc2)C(=O)Cn2nnc3ccccc32)cc1

3-aminopyridine-like Check Availability on Manifold View
CN(C)c1ccc(N(Cc2ccn[nH]2)C(=O)Cn2nnc3ccccc32)cc1

PET-UNK-1901c25b-3
Duplicate of:
PET-UNK-7374c256-2

CN(C)c1ccc(N(Cc2ccn[nH]2)C(=O)Cn2nnc3ccccc32)cc1

Duplicate 3-aminopyridine-like Assayed Check Availability on Manifold View

Design Rationale:

Three structural variations of ALP-POS-d2866bdf-1 (x10876) that are intended to map the structure-activity relationship for this series. [1] Replace P1 benzotriazole with isoquinoline (good P1 substituent in 3-aminoquinoline series) [2] Replace dimethylamino group with methylsulfonyl (this is intended to exploit shallow concave region on protein surface, will also make the benzene ring less electron rich and is likely to lead to better solubility) [3] Replace thiophene with pyrazole in attempt to donate a hydrogen bond to backbone carbonyl oxygen of E166 (this has been observed in fragment structures such as AAR-POS-d2a4d1df-2 (X0104).

Other Notes:

The docking file contains the protein and ligand structures for ALP-POS-d2866bdf-1 (X10876) and proposed binding modes for the three designs.

Inspired By:
Download PDB File
Discussion: